ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesG71.033

G71.033

Billable

Limb girdle muscular dystrophy due to dysferlin dysfunction

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 G71.033 is a billable code used to indicate a diagnosis of limb girdle muscular dystrophy due to dysferlin dysfunction.

Key Diagnostic Point:

Limb girdle muscular dystrophy (LGMD) due to dysferlin dysfunction is a genetic disorder characterized by progressive weakness and wasting of the proximal muscles, particularly those around the hips and shoulders. This condition is caused by mutations in the DYSF gene, which encodes the protein dysferlin, essential for muscle membrane repair. Patients typically present with muscle weakness in the late childhood to early adulthood period, often accompanied by muscle cramps and pain. The disease progresses variably, with some individuals experiencing significant disability while others maintain mobility into later life. Diagnosis is confirmed through genetic testing and muscle biopsy, which may show signs of myopathy. Dysferlinopathies are part of a broader category of muscular dystrophies, which also includes conditions like Duchenne and Becker muscular dystrophies. Management focuses on physical therapy, supportive care, and monitoring for complications such as respiratory issues or cardiomyopathy. Early diagnosis and intervention can help improve quality of life and functional outcomes.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Requires understanding of genetic testing results.
  • Differentiation from other types of muscular dystrophies.
  • Need for precise documentation of muscle weakness patterns.
  • Potential for co-existing conditions that may complicate coding.

Audit Risk Factors

  • Inadequate documentation of genetic testing.
  • Failure to specify the type of muscular dystrophy.
  • Misclassification of muscle weakness severity.
  • Omission of co-existing conditions.

Specialty Focus

Medical Specialties

Neurology

Documentation Requirements

Detailed neurological examination findings, genetic testing results, and muscle biopsy reports.

Common Clinical Scenarios

Patients presenting with progressive muscle weakness, difficulty climbing stairs, or frequent falls.

Billing Considerations

Ensure that all muscle groups affected are documented, and consider referrals to genetic counseling.

Physical Medicine and Rehabilitation

Documentation Requirements

Functional assessments, therapy progress notes, and patient mobility evaluations.

Common Clinical Scenarios

Rehabilitation plans for patients with muscle weakness and mobility issues.

Billing Considerations

Document the impact of muscle weakness on daily activities and the need for assistive devices.

Coding Guidelines

Inclusion Criteria

Use G71.033 When
  • Follow the official ICD
  • CM coding guidelines, ensuring accurate documentation of the condition's etiology and clinical manifestations
  • Include any relevant co
  • morbidities and specify the severity of muscle involvement

Exclusion Criteria

Do NOT use G71.033 When
No specific exclusions found.

Related ICD-10 Codes

Related CPT Codes

81401CPT Code

Genetic testing for dysferlin mutations

Clinical Scenario

Used when confirming a diagnosis of dysferlinopathy.

Documentation Requirements

Document the reason for testing and the specific mutations being analyzed.

Specialty Considerations

Neurology and genetics specialists should collaborate on testing.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 allows for more specific coding of muscular dystrophies, improving the accuracy of diagnoses and treatment plans. G71.033 provides a clear distinction for dysferlin-related conditions, facilitating better patient management and research opportunities.

ICD-9 vs ICD-10

The transition to ICD-10 allows for more specific coding of muscular dystrophies, improving the accuracy of diagnoses and treatment plans. G71.033 provides a clear distinction for dysferlin-related conditions, facilitating better patient management and research opportunities.

Reimbursement & Billing Impact

The transition to ICD-10 allows for more specific coding of muscular dystrophies, improving the accuracy of diagnoses and treatment plans. G71.033 provides a clear distinction for dysferlin-related conditions, facilitating better patient management and research opportunities.

Resources

Clinical References

  • •
    Muscular Dystrophy Association

Coding & Billing References

  • •
    Muscular Dystrophy Association

Frequently Asked Questions

What is the significance of the dysferlin gene in LGMD?

The dysferlin gene is crucial for muscle membrane repair. Mutations in this gene lead to the characteristic muscle weakness seen in limb girdle muscular dystrophy due to dysferlin dysfunction.